Skip to main content

Muscle Strength

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
1 program
Botulinum Toxin, Type AN/A1 trial
Active Trials
NCT00822523Completed13Est. Jul 2015
Clarity Pharmaceuticals
Clarity PharmaceuticalsAustralia - Eveleigh
1 program
VICTORY PATCHN/A1 trial
Active Trials
NCT06430879Completed100Est. Nov 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Clarity PharmaceuticalsVICTORY PATCH
AbbVieBotulinum Toxin, Type A

Clinical Trials (2)

Total enrollment: 113 patients across 2 trials

Performance Output With Haptics - Evaluating Athlete Response and Unrealized Potential

Start: Jul 2024Est. completion: Nov 2024100 patients
N/ACompleted
NCT00822523AbbVieBotulinum Toxin, Type A

Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction Studies

Start: Jan 2009Est. completion: Jul 201513 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.